Transitional Drugs 6
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)contractFind a Tender ↗Ref ocds-h6vhtk-05e923Procurement Act 2023SME suitableactive
Estimated value
—
Awarded value
—
Suppliers
12
Lots
1
1 awarded
Published
30 Mar 2026
Description
The provision of Drugs that have recently lost exclusivity
Scope
- Reference
- PHA-FTS-61082
- Commercial tool
- Standalone contract
- Contract dates
- 01 Mar 2026 to 29 Feb 2028Possible extension to 28 Feb 2030
24 month extension option available
- CPV classifications
- 33600000
- Contract locations
- Wales, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Product Quality/Acceptability | Pass/Fail | quality | 1.00% |
| Financial (overall cost of contract) | Weighting: 85 | cost | 2.00% |
| Enviromental/Social Value/Community Benefits | Weighting: 15 | quality | 3.00% |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded suppliers· 12 suppliers
Awarded —
Award value
—
Other contracts from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Accord UK Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| Generic Drugs – Injections/Infusions 2 | contract | — | 03 Mar 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 26 Nov 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |